报价延迟最少15分钟:2025/10/23 16:15 EDT
盘后时段
|
||||
|
31.37 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
31.37
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-8.22/1.41
|
|
企业价值
271.37M
|
| 资产负债 |
|
每股账面净值
-1.72
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
32.63M
|
|
每股收益
0.09
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/10/23 16:15 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing. |
